L&C Bio Decides to Acquire 71.62% Stake in Nano Focus Ray for 5 Billion KRW
[Asia Economy Reporter Lee Seon-ae] L&C Bio announced on the 16th that it has decided to acquire 1 million shares (71.62%) of Nanofocusray Co., Ltd., a manufacturer of medical radiation devices. The acquisition amount is 5 billion KRW, which corresponds to 6.52% of the company's equity capital.
The acquisition will be made through a third-party allotment paid-in capital increase and conversion of loans into equity, with the scheduled acquisition date being the 17th.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The company stated, "This is to create synergy effects with next-generation medical device products and to expand the range of products for entry into the Chinese market."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
